High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer

被引:9
|
作者
Song, Li [1 ]
Xing, Aiyan [2 ]
Li, Qiuju [1 ]
Wang, Guoyun [1 ]
机构
[1] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
美国国家科学基金会;
关键词
endometriosis-associated malignancy; rectal endometriosis; high-grade serous carcinoma; simultaneous primary carcinoma; ovarian cancer; ADENOCARCINOMA;
D O I
10.3389/fonc.2019.01252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometriosis is one of the most common benign gynecological diseases. It shows similar attributes to those of some fatal tumors if it is becomes malignant. These attributes include invasion, implantation, and recurrence. Epidemiological, clinicopathological, molecular biological, and genetic evidence suggest that malignancy of endometriosis, referred to as endometriosis-associated malignancy (EAM), is histologically closely related to endometriosis. Atypical endometriosis, which usually causes EAM, is considered a transitional condition from benign endometriosis to cancer. Approximately 80% of EAMs occur in the ovary and are known as endometriosis-associated ovarian cancer (EAOC). However, extragonadal endometriosis is not common, and no earlier study reported an association between malignant transformation of rectal endometriosis and high-grade serous cancer. We report a rare case of high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. A 63-year-old Chinese woman was admitted with a complaint of abdominal distension. We diagnosed the patient with ovarian carcinoma and decided on elective cytoreductive surgery as treatment for the patient. During the surgery, we found a solid mass of diameter 12 cm in the anterior rectal wall containing sticky brown fluid. Postoperative histopathological examination revealed high-grade serous carcinoma resulting from rectal endometriosis and complicated with ovarian cancer. The patient postoperatively received 6 cycles of chemotherapy consisting of carboplatin and paclitaxel and was followed up for 1 year with no recurrence of the condition.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Characteristics of 10-year survivors of high-grade serous ovarian carcinoma
    Dao, Fanny
    Schlappe, Brooke A.
    Tseng, Jill
    Lester, Jenny
    Nick, Alpa M.
    Lutgendorf, Susan K.
    McMeekin, Scott
    Coleman, Robert L.
    Moore, Kathleen N.
    Karlan, Beth Y.
    Sood, Anil K.
    Levine, Douglas A.
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 260 - 263
  • [42] Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
    S L Cooke
    C K Y Ng
    N Melnyk
    M J Garcia
    T Hardcastle
    J Temple
    S Langdon
    D Huntsman
    J D Brenton
    Oncogene, 2010, 29 : 4905 - 4913
  • [43] Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma
    Komiyama, Shinichi
    Nishijima, Yoshihiro
    Kondo, Haruhiro
    Nomura, Hiroyuki
    Yamaguchi, Satoshi
    Futagami, Masayuki
    Arai, Hiroharu
    Yokoyama, Yoshihito
    Suzuki, Nao
    Mikami, Mikio
    Kubushiro, Kaneyuki
    Aoki, Daisuke
    Udagawa, Yasuhiro
    Nishimura, Ryuichiro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (04) : 657 - 665
  • [44] GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer
    El-Arabey, Amr Ahmed
    Abdalla, Mohnad
    Abd-Allah, Adel Rashad
    HUMAN CELL, 2020, 33 (03) : 904 - 906
  • [45] GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer
    Amr Ahmed El-Arabey
    Mohnad Abdalla
    Adel Rashad Abd-Allah
    Human Cell, 2020, 33 : 904 - 906
  • [46] Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma
    Zarei, Shabnam
    Wang, Yan
    Jenkins, Sarah M.
    Voss, Jesse S.
    Kerr, Sarah E.
    Bell, Debra A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (03) : 316 - 328
  • [47] Isolated splenic high-grade serous carcinoma: A case report
    Rogers, Ralph
    Ehmann, Sarah
    Tew, William P.
    Broach, Vance
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [48] Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
    Cardillo, Nicholas
    Devor, Eric J.
    Pedra Nobre, Silvana
    Newtson, Andreea
    Leslie, Kimberly
    Bender, David P.
    Smith, Brian J.
    Goodheart, Michael J.
    Gonzalez-Bosquet, Jesus
    CANCERS, 2022, 14 (14)
  • [49] Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Matsuzaki, Juntaro
    Yoshida, Kosuke
    Yamamoto, Yusuke
    Kato, Tomoyasu
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    CANCER MEDICINE, 2024, 13 (22):
  • [50] High-throughput approaches for precision medicine in high-grade serous ovarian cancer
    Govindarajan, Meinusha
    Wohlmuth, Christoph
    Waas, Matthew
    Bernardini, Marcus Q.
    Kislinger, Thomas
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)